I en populationsfarmakokinetisk analyse er det imidlertid ikke vist at alder og nedsat nyrefunktion påvirker den systemiske clearance af trastuzumab.
However in a population pharmacokinetic analysis, age and renal impairment were not shown to affect trastuzumab disposition.